484 related articles for article (PubMed ID: 38035338)
21. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer.
Azimi M; Keshavarz Shahbaz S; Mansourabadi AH; Mohamed Khosroshahi L; Pourkalhor S; Rezakhani M; Masoumi F
Int Arch Allergy Immunol; 2022; 183(11):1147-1165. PubMed ID: 35988536
[TBL] [Abstract][Full Text] [Related]
22. The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer.
Sillo TO; Beggs AD; Middleton G; Akingboye A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982838
[TBL] [Abstract][Full Text] [Related]
23. Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer.
Huang J; Zheng X; Kang W; Hao H; Mao Y; Zhang H; Chen Y; Tan Y; He Y; Zhao W; Yin Y
Front Immunol; 2022; 13():874922. PubMed ID: 35911731
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
Fong W; Li Q; Yu J
Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
Wang J; Zhu N; Su X; Yang R
Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
[TBL] [Abstract][Full Text] [Related]
26. Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.
Kashyap S; Das A
Acta Microbiol Immunol Hung; 2023 Jun; 70(2):85-99. PubMed ID: 37307215
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
[TBL] [Abstract][Full Text] [Related]
29. Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light.
Zhang J; Wu K; Shi C; Li G
Curr Treat Options Oncol; 2022 Dec; 23(12):1777-1792. PubMed ID: 36279081
[TBL] [Abstract][Full Text] [Related]
30. Complex interactions between the microbiome and cancer immune therapy.
Schwartz DJ; Rebeck ON; Dantas G
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
[TBL] [Abstract][Full Text] [Related]
31. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
Kim J; Lee HK
Front Immunol; 2021; 12():807648. PubMed ID: 35069592
[TBL] [Abstract][Full Text] [Related]
32. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy.
Kang X; Lau HC; Yu J
Cell Rep Med; 2024 Apr; 5(4):101478. PubMed ID: 38631285
[TBL] [Abstract][Full Text] [Related]
33. Role of gut microbiome on immunotherapy efficacy in melanoma.
Bibbò S; Ianiro G; Giambò F; Settanni CR; Cammarota G; Gasbarrini A
Hum Vaccin Immunother; 2022 May; 18(3):1926759. PubMed ID: 34190675
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention.
Zhang W; Zhang J; Liu T; Xing J; Zhang H; Wang D; Tang D
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2387-2404. PubMed ID: 35661254
[TBL] [Abstract][Full Text] [Related]
36. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure.
Velikova T; Krastev B; Lozenov S; Gencheva R; Peshevska-Sekulovska M; Nikolaev G; Peruhova M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578709
[TBL] [Abstract][Full Text] [Related]
38. Strategies for the treatment of colorectal cancer caused by gut microbiota.
de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF
Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161
[TBL] [Abstract][Full Text] [Related]
39. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
40. Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.
Chang CW; Lee HC; Li LH; Chiang Chiau JS; Wang TE; Chuang WH; Chen MJ; Wang HY; Shih SC; Liu CY; Tsai TH; Chen YJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
